SCI时时刷

search
Case 6-2021: A 65-Year-Old Man with Eye Pain and Decreased Vision
Case 6-2021: A 65-Year-Old Man with Eye Pain and Decreased Vision
A Man with Eye Pain and Decreased Vision A 65-year-old man with Waldenström’s macroglobulinemia was evaluated because of a...
Atopic Dermatitis
Atopic Dermatitis
Atopic Dermatitis Atopic dermatitis is a chronic disorder that usually starts in childhood but often persists in adulthood...
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Abstract Background The oral Janus kinase 1 (JAK1) inhibitor abrocitinib, which reduces interleukin-4 and interleukin-13 s...
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
Abstract Background The Janus kinase inhibitor upadacitinib is a potential treatment for psoriatic arthritis. The efficacy...
Sunken Nose
Sunken Nose
Images in Clinical Medicine from The New England Journal of Medicine — Sunken Nose
Case 16-2021: A 37-Year-Old Woman with Abdominal Pain and Aortic Dilatation
Case 16-2021: A 37-Year-Old Woman with Abdominal Pain and Aortic Dilatation
A Woman with Abdominal Pain and Aortic Dilatation A 37-year-old woman with a history of injection-drug use was admitted wi...
Gastrointestinal Amyloidosis
Gastrointestinal Amyloidosis
Images in Clinical Medicine from The New England Journal of Medicine — Gastrointestinal Amyloidosis
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris
Abstract Background Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequ...
Bimekizumab versus Adalimumab in Plaque Psoriasis
Bimekizumab versus Adalimumab in Plaque Psoriasis
Abstract Background Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits interleukin-17A and interleukin-17...
Bimekizumab versus Secukinumab in Plaque Psoriasis
Bimekizumab versus Secukinumab in Plaque Psoriasis
Abstract Background Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits both interleukin-17A and interleuk...